Suchergebnisse
Suche
Disclosure Report 1712
credit risk) 62 5.2 General information concerning the credit risk 67 5.3 Credit risk mitigation techniques 81 5.4 Standard approach 85 5.5 IRB approach 89 5.6 Counterparty credit risk 113 5.7 Shareholdings in the banking book 122 5.8 Securitisations 125 6
Offenlegungsbericht 2210
übermäßigen Verschuldung (%) 2,5 2,5 2,5 2,5 2,5 EU 7b davon: in Form von CET1 vorzuhalten ( [...] SREP-Gesamtkapitalanforderung (%) 10,5 10,5 10,5 10,5 10,5 Kombinierte Kapitalpuffer- und Gesamtkapitalanforderung [...] gewichteter Wert – Durchschnitt) 5.837 5.961 5.808 5.778 5.728 EU 16a Mittelabflüsse – Gewichteter
Disclosure Report 31.12.2018
credit risk) 70 5.2 General information concerning the credit risk 75 5.3 Credit risk mitigation techniques 91 5.4 Standard approach 95 5.5 IRB approach 100 5.6 Counterparty credit risk 125 5.7 Shareholdings in the banking book 134 5.8 Securitisations 137 6
Offenlegungsbericht 31.12.2018
Gegenparteiausfallrisiko) 71 5.2 Allgemeine Angaben zum Adressenausfallrisiko 77 5.3 Kreditrisikominderungstechniken 94 5.4 Standardansatz 98 5.5 IRB-Ansatz 103 5.6 Gegenparteiausfallrisiko 129 5.7 Beteiligungen im Anlagebuch 140 5.8 Verbriefungen 143 6 Marktrisiko
pbb company presentation January 2023
1.1 3.0 20212020 9M/22 7.4 2.3 6.6 9.1 1.6 2.0 1.7 3.3 2.1 2.2 2.1 Q4 Q1 Q3 Q2 RoE b.t.1,5 4.6% 7.5% [...] 21 FY21 9M/22 Total volume (€ bn) 5.7 9.0 6.6 thereof: Extensions >1 year 1.7 2.6 1.8 No. of deals 103 [...] 18.9 19.0 18.1 Own funds 22.4 22.5 21.5 Leverage ratio 6.0 5.74 5.64 Capital in € bn 12/211 06/222,3
pbb company presentation 2211
21 FY21 9M/22 Total volume (€ bn) 5.7 9.0 6.6 thereof: Extensions >1 year 1.7 2.6 1.8 No. of deals 103 [...] 2.4 0.5 1.5 9M/22: € 4.8 bn Tenor (avg, yrs)3 5.5 7.3 3.6 12 8 102Spread [...] 18.9 19.0 18.1 Own funds 22.4 22.5 21.5 Leverage ratio 6.0 5.74 5.64 Capital in € bn 12/211 06/222,3
Investor Update Q32022 e
2.33.0 3.3 7.4 1.1 2020 2021 9M/22 6.6 9.1 Q4 Q3 Q2 Q1 RoE b.t.1,5 7.5% 4.6% 6.3% 52 42 62 6574 72 5247 [...] 21 FY21 9M/22 Total volume (€ bn) 5.7 9.0 6.6 thereof: Extensions >1 year 1.7 2.6 1.8 No. of deals 103 [...] 18.9 19.0 18.1 Own funds 22.4 22.5 21.5 Leverage ratio 6.0 5.74 5.64 Capital in € bn 12/211 06/222,3
Investor Update Q32022 d vf
159 77%74% 75% 44,2 11,4 4,8 2020 5,8 5,2 2021 9M/22 43,7 44,3 27,0 10,9 27,6 10,0 29,5 REFVP PIF Strat [...] 21 9M/2022 Gesamtvolumen (Mrd. €) 5,7 9,0 6,6 davon: Prolongationen > 1 J. 1,7 2,6 1,8 Anzahl der [...] 18,9 19,0 18,1 Eigenmittel 22,4 22,5 21,5 Leverage Ratio 6,0 5,74 5,64 Eigenkapital in Mrd. € 12/211 06
Investor Update Q32022 de
159 77%74% 75% 44,2 11,4 4,8 2020 5,8 5,2 2021 9M/22 43,7 44,3 27,0 10,9 27,6 10,0 29,5 REFVP PIF Strat [...] 21 9M/2022 Gesamtvolumen (Mrd. €) 5,7 9,0 6,6 davon: Prolongationen > 1 J. 1,7 2,6 1,8 Anzahl der [...] 18,9 19,0 18,1 Eigenmittel 22,4 22,5 21,5 Leverage Ratio 6,0 5,74 5,64 Eigenkapital in Mrd. € 12/211 06
pbb company presentation 0921
74%74% 6.3 12.1 11.4 27.1 2019 5.8 27.0 2020 11.1 H1/21 5.5 26.8 45.5 44.2 43.4 VP PIF REF Strategic [...] on non-financial assets -15 -18 -5 -5 -4 -5 -19 -5 -4 -9 Net income from restructuring -9 3 - - - - [...] /21 H1/21 CIR1 76.3 75.0 55.6 45.5 45.5 60.0 51.2 55.6 55.6 55.6 RoE before tax 5.4 2.7 1.5 11.4 9.9